Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)
China · Delayed Price · Currency is CNY 39.16
+1.00 (2.62%)
At close: Mar 6, 2026
Assure Tech (Hangzhou) Revenue
In the year 2025, Assure Tech (Hangzhou) had annual revenue of 453.58M CNY, down -16.11%. Assure Tech (Hangzhou) had revenue of 128.29M in the quarter ending December 31, 2025, a decrease of -6.65%.
Revenue
453.58M
Revenue Growth
-16.11%
P/S Ratio
10.97
Revenue / Employee
612.11K
Employees
720
Market Cap
4.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 453.58M | -87.12M | -16.11% |
| Dec 31, 2024 | 540.70M | 37.34M | 7.42% |
| Dec 31, 2023 | 503.36M | -5.66B | -91.84% |
| Dec 31, 2022 | 6.17B | 4.58B | 287.97% |
| Dec 31, 2021 | 1.59B | 389.51M | 32.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Hvsen Biotechnology | 1.67B |
| Hefei Lifeon Pharmaceutical | 1.47B |
| Pulike Biological Engineering | 1.10B |
| ChemPartner PharmaTech | 1.07B |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| PharmaResources (Shanghai) | 667.47M |
| Hangzhou Biotest Biotech | 448.37M |
| Innovita Biological Technology | 422.03M |